CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Activity

26 hedge funds and large institutions have $1.2M invested in COSCIENS Biopharma Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
9
Closed
5
Calls
$47K
Puts
–
Net Calls
+$47K
Net Calls Change
-$103K

Top Buyers

1
IC
1
Ikarian Capital
Texas
$107K
2
Morgan Stanley
2
Morgan Stanley
New York
$699K
3
SM
3
Sabby Management
Florida
$93K
4
UBS Group
4
UBS Group
Switzerland
$2K
5
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Quebec, Canada
$34.1K

Top Sellers

1
AC
1
Armistice Capital
New York
$0
2
BFM
2
Boothbay Fund Management
New York
$22K
3
OSAM
3
O'Shaughnessy Asset Management
Connecticut
$0
4
VF
4
Virtu Financial
New York
$19K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$46K
Name Market Value Shares Shares
Change 		Shares
Change %
Group One Trading
26
Group One Trading
Illinois
$0 447 -632 -59%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$0 188 -360 -66%
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$0 44 – –
JFA
29
JNBA Financial Advisors
Minnesota
$0 91 – –
LTFS
30
Ladenburg Thalmann Financial Services
Florida
$0 3 – –
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
Simplex Trading
32
Simplex Trading
Illinois
– – – –
LFA
33
Lighthouse Financial Advisors
Maryland
$0 550 +550 New
1
2